Who
Nathan B. Fountain
Director
Company insider
Files Form 4 as: Director, Acumen Pharmaceuticals.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 1
- Bought
- $100K
- Sold
- $29K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Jun 2021
- Last trade
- 9 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 10 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $14K6,400 at $2.23 | filing |
| 9 Jun 2026filed 10 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $14K6,400 at $2.23 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,250 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,250 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —12,800 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jun 2023filed 7 Jun 2023 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jul 2021filed 8 Jul 2021 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $100K6,250 at $16.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.